Organogenesis Holdings, Inc. (ORGO)
2.24
-0.07
(-3.03%)
USD |
NASDAQ |
Apr 02, 16:00
2.24
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings EPS Diluted (Quarterly) : 0.2657 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 43.70M |
| Revenue (Quarterly) | 225.61M |
| Total Expenses (Quarterly) | 181.91M |
| Enterprise Value | 409.75M |
| Gross Profit Margin (Quarterly) | 74.77% |
| Profit Margin (Quarterly) | 19.37% |
| Earnings Yield | 4.89% |
| Operating Earnings Yield | 19.65% |
| Normalized Earnings Yield | 7.853 |